Industry

Wall Street Journal reporter James Hagerty writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation known for his work as a pioneering leader in the field of biotechnology.

Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a transformational leader in biotechnology of orphan diseases. Many children now have hope of a healthy life because of his vision and 40 years of creative business leadership.”

Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”

In an article for The Boston Globe’s 2017 “Game Changers” section - which highlights ideas, inventions, people and places making waves in Boston - Robert Weisman spotlights The Engine. “We hope to create world-changing companies that will grow in the Boston region,” explains Katie Rae, The Engine’s President and CEO.

In an article for Forbes about how companies and colleges need to collaborate more to spur innovation, Harold Sirkin writes that “MIT has mastered the art of industry collaboration.”

A report released by MIT startup Cambridge Mobile Telematics (CMT) shows that one in four drivers were using a smartphone just before an accident occurred, reports The Boston Globe’s Matt Rocheleau. Prof. Samuel Madden, founder and chief scientist at CMT, explains that the study shows “people are using their phones a lot, and that’s playing a role in the accidents.” 

Reporting for the PBS NewsHour, Nsikan Akpan highlights a new study co-authored by MIT researchers that examines how many NIH grants lead to new patents and medications. Prof. Pierre Azoulay explains that the study, “provides evidence that the research done in the public sector is useful — it’s relevant for the research done by private-sector firms.”

Newsweek reporter Jessica Wapner writes about a new study by MIT researchers that provides evidence that NIH funding contributes to a large number of patents in the field of biomedicine. The findings indicate that NIH-funded research “is not being done in an ivory tower,” explains Prof. Pierre Azoulay. “Companies use it as input in their own discovery efforts.”   

Nature reporter Elie Dolgin writes about Prof. Pierre Azoulay’s new research that shows NIH funding has a significant impact on innovation in the field of biomedicine. Azoulay explains that from an economic standpoint the U.S. is “under-investing overall” in biomedical research.

Los Angeles Times reporter Melissa Healy writes that a new study by Prof. Pierre Azoulay examining the impact of NIH-funded research shows that NIH funding, “fuels the kinds of innovations that drive the U.S. economy.” Azoulay explains, “NIH public funding expenditures have large effects on the patenting output of the private sector.”  

A study by Prof. Pierre Azoulay demonstrates the significant impact of NIH funding on biomedical patents, reports Carolyn Johnson for The Washington Post. Azoulay explains, “if your view was that the research done by academics...[has] no ramifications for the real world and the development of new medicines — well, that view is not correct.” 

WBUR reporter Asma Khalid reports on how The Engine could help the Boston-area innovation ecosystem. Katie Rae, president and CEO of The Engine, explains that The Engine will support startups focused on tough technologies, which “take longer than most venture capital firms want to take bets on."

Katie Rae, president and CEO of The Engine, speaks with Meghna Chakrabarti of Radio Boston about her new role and why The Engine is aimed at addressing the gap between science and commercialization. Rae explains that The Engine will be focused on “investing very early into the translational stage for science-oriented startups.”

Writing for The Washington Post, Prof. Maria Zuber, MIT’s vice president for research, outlines how the U.S. can reduce coal emissions without “declaring war on coal communities.” Zuber argues that the U.S. must “commit to helping the workers and communities that are hurt when coal mines and coal plants reduce their operations or shut down.” 

Oscar Williams of The Huffington Post writes that MIT researchers have designed a coating that allows liquids to slid out of containers, which could cut down on food waste. “In packages there are about 40 billion packs with material stuck in packages so the technology has the potential to significantly reduce waste,” says MIT alumnus and LiquiGlide co-founder David Smith.